STUDIES

Current Drug Trials in ALS (updated 2/23/10)

"Clinical Trial of Ceftriaxone in Subjects with ALS"
Sponsor: National Institute of Neurological Disorders and Stroke (NINDS)
Status: Recruiting
More information about this study

"Phase II/III Randomized, Placebo-Controlled Trial of Arimoclomol in SOD1 Positive Familial Amyotrophic Lateral Sclerosis"
Sponsor: Emory University and the ALS Association
Status: Recruiting
More information about this study

"Safety and Tolerability of the Ketogenic Diet in Amyotrophic Lateral Sclerosis (ALS)"
Sponsor: Weill Medical College of Cornell University
Status: Recruiting
More information about this study

"Talampanel for Amyotrophic Lateral Sclerosis"
Sponsor: Teva Pharmaceutical Industries
Status: Active, no longer recruiting
More information about this study

"Clinical Trial of SB-509 in Subjects with Amyotrophic Lateral Sclerosis"
Sponsor: Sangamo Biosciences
Status: Active, no longer recruiting
More information about this study

"Safety and Tolerability Study of KNS-760704 in Amyotrophic Lateral Sclerosis (ALS) (CL201)"
Sponsor: Knopp Neurosciences
Status: Completed
More information about this study

"Study to Investigate the Safety and Efficacy of Lithium in Volunteers with ALS"
Sponsor: National Institute of Neurological Disorders and Stroke (NINDS)
Status: Terminated
More information about this study

Current Non-Drug Trials in ALS (updated 2/23/10)

"A Multicenter Study for the Validation of ALS Biomarkers"
Sponsor: Massachusetts General Hospital & ALS Association
Status: Recruiting
More information about this study

"The Pre-familial ALS (pre-fALS) Study"
Sponsor: Emory University
Status: Recruiting
More information about this study

"ATLIS"
Sponsor: Muscular Dystrophy Association
Status: Recruiting
More information about this study

More about Clinical Trials

What is a Clinical Trial? (PDF)

Dina Scholtz, MD California Pacific Medical Center


Home | What's New | Studies | Newsletters | Meeting Summaries
Educational Materials | Login | For Health Professionals | FAQs | Resources and Links
 


This website is funded by an unrestricted grant from MDA.